Gynecological Cancer

Tailor treatment through targeted, next-generation sequencing

Mayo Clinic Laboratories’ MayoComplete gynecological cancer panels use next-generation sequencing to evaluate genes with known relevance to diagnosis, prognosis, and treatment of uterine, ovarian, and endometrial cancers. An integrated team of gynecologic clinicians, geneticists, and genetic counselors carefully designed our panels to include only clinically actionable genes.

Gynecological Cancer Test menu

Next-generation sequencing panels

Patient-centric, cost-effective, and efficient, our panels provide a detailed picture of a patient’s illness to help understand the best path forward. Identifying a pathogenic variant can also support familial screening and genetic counseling for a variety of hereditary cancer syndromes.

Key testing


Single-gene testing


Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.